Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
LOXL4
REST API REST API
Homo sapiens
LOXL4 is differentially expressed in 118 experiments: 65 organism parts: cerebellum, mammary gland, ... (63 more);, 47 disease states: normal, AF, ... (45 more);, 45 cell types 239 cell lines 10 compound treatments and 43 other conditions.
Synonyms FLJ21889, LOXC
Orthologs LOXL4_BOVIN (Bos taurus)   Loxl4 (Rattus norvegicus)   ENSCING00000006336 (Ciona intestinalis)   LOXL4 (Gallus gallus)   lox2 (Drosophila melanogaster)   Loxl4 (Mus musculus)   LOXL4 (2 of 3) (Danio rerio)   LOXL4 (1 of 3) (Danio rerio)   loxl4 (Danio rerio)   loxl4 (Xenopus laevis)   LOXL4 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term oxidoreductase activity, protein binding, scavenger receptor activity, extracellular space, membrane, metal ion binding, extracellular region, oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor, protein-lysine 6-oxidase activity, copper ion binding, oxidation-reduction process
InterPro Term Lysyl_oxidase, Srcr_rcpt, Srcr_rcpt-rel
UniProt Accession Q96JB6
Search EB-eye ENSG00000138131
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-6573, E-GEOD-6919, E-TABM-130, E-GEOD-3526, ... (13 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-17482, E-GEOD-14464, E-GEOD-19639, E-GEOD-24147, ... (19 experiments)

Factor Value U/D Experiments
A549
2
E-GEOD-6013, E-GEOD-3202
U87
2
E-MEXP-903, E-GEOD-20089
OE19
1
E-MTAB-37
HOS
1
E-MTAB-37
MCF-10A
1
E-GEOD-14990
HuT78
1
E-MTAB-37
233 more value(s).


Cell type

studied in E-GEOD-15893, E-AFMX-5, E-GEOD-18811, E-MEXP-2488, E-GEOD-22373, ... (23 experiments)

Factor Value U/D Experiments
naive B cell
1
E-TABM-702
partially reprogrammed human induced pluripotent stem cell
1
E-GEOD-18265
fibroblast
1
E-GEOD-26672
immortalized cell culture
1
E-GEOD-14990
adipocyte
1
E-AFMX-5
macrophage
1
E-GEOD-22373
39 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-19743, E-GEOD-6872, E-GEOD-2508, E-MEXP-1072, ... (19 experiments)

Factor Value U/D Experiments
bronchogenic carcinoma
1
E-MTAB-37
n/a
1
E-GEOD-19743
nodal peripheral T-cell lymphoma
1
E-TABM-702
B-cell neoplasm
1
E-MTAB-37
acute lymphoblastic leukemia
1
E-MTAB-37
NDV
1
E-GEOD-18791
41 more value(s).


Compound treatment

studied in E-GEOD-3284, E-TABM-127, E-MEXP-2241, E-MEXP-2590, E-GEOD-7307, ... (6 experiments)

Factor Value U/D Experiments
TTA
1
E-MEXP-2590
unknown
1
E-GEOD-7307
bacterial endotoxin
1
1
E-GEOD-3284
control
10
1
E-GEOD-3284
ethanol
1
E-MEXP-2241
NaOH
1
E-MEXP-2590
4 more value(s).


Age at diagnosis

studied in E-GEOD-3494, E-GEOD-4922

Factor Value U/D Experiments
77
1
E-GEOD-3494
77 years
1
E-GEOD-4922


Agent
studied in E-GEOD-19519

BioSourceProvider
studied in E-GEOD-19519

Cancer site
studied in E-GEOD-4271

Clinical history
studied in E-GEOD-22097, E-GEOD-7967, E-GEOD-21610

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-21374

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-GEOD-4667

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-3325, E-GEOD-21138, E-GEOD-19665

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-7578, E-GEOD-20847, E-MEXP-563

Genotype
studied in E-GEOD-3494, E-GEOD-17347

Growth condition
studied in E-MEXP-2657, E-TABM-127, E-GEOD-9764, E-GEOD-10315, E-MEXP-1103 ... (5 experiments)

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-TABM-325, E-MEXP-2069, E-TABM-666, E-GEOD-19519, E-GEOD-6919, ... (16 experiments)

Infection
studied in E-GEOD-12108

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-22056, E-GEOD-12662

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

P53 ihc
studied in E-GEOD-21653

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-17636

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-19445, E-GEOD-20037

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-4922, E-GEOD-19188

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-19246, E-GEOD-15799

Tumor grading
studied in E-GEOD-4922

Tumor size
studied in E-GEOD-3494, E-GEOD-4922

Processing time: 0.489 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM